scholarly journals The chemistry of low dosage clathrate hydrate inhibitors

2013 ◽  
Vol 42 (5) ◽  
pp. 1996 ◽  
Author(s):  
Andrea Perrin ◽  
Osama M. Musa ◽  
Jonathan W. Steed
Keyword(s):  
2010 ◽  
Vol 287 (1) ◽  
pp. 168-176 ◽  
Author(s):  
Tatiana Kuznetsova ◽  
Alla Sapronova ◽  
Bjørn Kvamme ◽  
Klaus Johannsen ◽  
Jarle Haug

ChemInform ◽  
2013 ◽  
Vol 44 (24) ◽  
pp. no-no
Author(s):  
Andrea Perrin ◽  
Osama M. Musa ◽  
Jonathan W. Steed
Keyword(s):  

Pathology ◽  
1993 ◽  
Vol 25 (1) ◽  
pp. 24-26 ◽  
Author(s):  
Pek-Yoon Chong ◽  
Thiow-Kong Ti

2021 ◽  
Vol 105 ◽  
pp. 307-311 ◽  
Author(s):  
Bastian Steuwer ◽  
Euzebiusz Jamrozik ◽  
Nir Eyal
Keyword(s):  

1988 ◽  
Vol 3 (2) ◽  
pp. 125-130
Author(s):  
D.M. Dieterle ◽  
M. Ackenheil ◽  
H.P. Kapfhammer ◽  
F. Müller-Spahn

RésuméZotepine was studied in 15 schizophrenic patients over a period of 28 days with regard to its antipsychotic efficacy, effect on negative schizophrenic symptoms, tolerability and adverse effects. Nine patients received Zotepine in a high dosage of 230 mg/die±52 mg, 6 patients in a low dosage of 168 mg/die ± 18 mg. Two patients receiving the high dosage dropped out after 21 days because of worsening of symptomatology and suicide attempts. Zotepine had rapid antipsychotic effects with sedative properties during the initial days of treatment. Minimal adverse effects and extra-pyramidal motor disturbances as well as dose-dependent positive effects on negative schizophrenie symptoms were found.


Sign in / Sign up

Export Citation Format

Share Document